<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72162">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01869842</url>
  </required_header>
  <id_info>
    <org_study_id>1-2011-0070</org_study_id>
    <nct_id>NCT01869842</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Study of the Traditional Percutaneous Coronary Intervention and Intervention Using Optical Coherence Tomography of Incomplete Stent Adhesion and Extent of the Formation of Neointima by Resolute Zotarolimus-eluting Stent Insertion</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>South Korea: Korea Food and Drug Administration (KFDA)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Optical coherence tomography (OCT) after the stent procedure to improve the adhesion and
      expansion, or incomplete uncovered struts attached to the main track. OCT in clinical areas
      by improving the parameters of the best stent will be useful. However, for better results
      for optical coherence tomography in percutaneous interventions have little useful data on
      the role. Randomized controlled study of the traditional percutaneous coronary intervention
      and intervention using optical coherence tomography.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>ratio of the stent strut</measure>
    <time_frame>Angiographic follow-up with OCT at 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">115</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Stable Angina</condition>
  <condition>Unstable Angina</condition>
  <arm_group>
    <arm_group_label>DM, angio group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DM, OCT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>non DM, angio group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>non DM, OCT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>percutaneous coronary intervention</intervention_name>
    <description>the traditional percutaneous coronary intervention by Resolute zotarolimus-eluting stent insertion</description>
    <arm_group_label>DM, angio group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OCT-guided percutaneous coronary intervention</intervention_name>
    <description>the percutaneous coronary intervention using optical coherence tomography by Resolute zotarolimus-eluting stent insertion</description>
    <arm_group_label>DM, OCT group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>percutaneous coronary intervention</intervention_name>
    <description>the traditional percutaneous coronary intervention by Resolute zotarolimus-eluting stent insertion</description>
    <arm_group_label>non DM, angio group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OCT-guided percutaneous coronary intervention</intervention_name>
    <description>the percutaneous coronary intervention using optical coherence tomography by Resolute zotarolimus-eluting stent insertion</description>
    <arm_group_label>non DM, OCT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Single lesion in a Single vessel

          -  Reference vessel diameter 2.5 - 3.5 mm

          -  Lesion length ≤ 34 mm and ≤ 34 mm stent length

          -  Stable angina requiring revascularization, patients with unstable angina

          -  The patient has no difficulty to enforce the follow-up angiography

          -  Patient is ≥ 20 years old

        Exclusion Criteria:

          -  Lesions with graft vessel, thrombosis, restenosis, and bifurcation requiring 2 stents

          -  Reference vessel diameter &lt; 2.5 mm or &gt; 4.0mm

          -  Contraindication to anti-platelet agents

          -  Treated with any DES within 3 months at other vessel

          -  Creatinine level ≥ 2.0 mg/dL or ESRD

          -  Severe hepatic dysfunction (3 times normal reference values)

          -  Patients with LVEF &lt; 30%

          -  Life expectancy 1 year

          -  Lesions with CTO or left main

          -  Target vessel of ST-elevation MI

          -  Lesions requiring overlapped stenting or more than 2 DES in each vessel

          -  Heavy calcified lesions (definite calcified lesions on angiogram)

          -  Far distal or tortuous lesions having difficulties in OCT evaluation or follow-up OCT

          -  Pregnant women or women with potential childbearing
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Myeong Ki Hong, Md, PhD</last_name>
    <phone>82-2-2228-8460</phone>
    <email>mkhong61@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MyeongKi Hong, MD, PhD</last_name>
      <phone>82-2-2228-8460</phone>
      <email>mkhong61@yuhs.ac</email>
    </contact>
    <investigator>
      <last_name>Myeong Ki Hong, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>June 4, 2013</lastchanged_date>
  <firstreceived_date>May 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Resolute zotarolumus-eluting stent</keyword>
  <keyword>optical coherence tomography</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
